Giorgio Sesti

Pubblicazioni

Titolo Pubblicato in Anno
Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet–induced obesity and its metabolic complications in male mice MOLECULAR METABOLISM 2020
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus. data from an in vivo model NUTRIENTS 2020
Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects NUTRIENTS 2020
The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020
Reduction in global myocardial glucose metabolism in subjects with 1-h postload hyperglycemia and impaired glucose tolerance DIABETES CARE 2020
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice DIABETES, OBESITY AND METABOLISM 2020
Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
Association between serum Mg2+ concentrations and cardiovascular organ damage in a cohort of adult subjects NUTRIENTS 2020
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2020
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2020
Alkaline phosphatase affects renal function in never-treated hypertensive patients. effect modification by age SCIENTIFIC REPORTS 2020
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9) DIABETES CARE 2020
Serum γ-Glutamyltransferase Concentration Predicts Endothelial Dysfunction in Naïve Hypertensive Patients BIOMEDICINES 2020
Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance CARDIOVASCULAR DIABETOLOGY 2020
Uric acid and vascular damage in essential hypertension. role of insulin resistance NUTRIENTS 2020
The contribution of unrecognized factors to the diabetes epidemic DIABETES/METABOLISM RESEARCH AND REVIEWS 2020
Liraglutide increases serum levels of microRNA-27b, -130a and -210 in patients with type 2 diabetes mellitus. a novel epigenetic effect METABOLITES 2020
Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy DRUGS - REAL WORLD OUTCOMES 2020
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG). Case Report SN COMPREHENSIVE CLINICAL MEDICINE 2020
Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance DIABETES/METABOLISM RESEARCH AND REVIEWS 2020

ERC

  • LS4_9
  • LS4_10

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

- Meccanismi molecolari dell’azione insulinica e della funzione pancreatica;

- Fisiopatologia del diabete tipo 2 e dell’obesità;

- Genetica dell’insulino-resistenza, del diabete tipo 2 e dell’obesità;

- Sindrome metabolica e prediabete;

- Obesità metabolicamente sana;

- Trattamento del diabete tipo 2;

- Ruolo dell’IGF-1 nella patologia cardiovascolare e metabolica;

- Infiammazione, disfunzione endoteliale e patologia cardiovascolare;

- Epatopatie croniche e danno cardio-metabolico

Keywords

Diabetes Mellitus
obesity
cardiovascular disease

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma